Your browser doesn't support javascript.
loading
[A favorable clinical course of acute myeloid leukemia with t (6;21;8)(p23;q22;q22)].
Wada, Atsushi; Doki, Noriko; Otsuka, Yuki; Adachi, Hiroto; Konuma, Ryosuke; Kishida, Yuya; Konishi, Tatsuya; Yamada, Yuta; Nagata, Akihito; Nagata, Ryohei; Marumo, Atsushi; Noguchi, Yuma; Mukae, Junichi; Toya, Takashi; Igarashi, Aiko; Najima, Yuho; Kobayashi, Takeshi; Harada, Hironori; Harada, Yuka; Sakamaki, Hisashi; Ohashi, Kazuteru.
Afiliação
  • Wada A; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Otsuka Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Adachi H; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Konuma R; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Kishida Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Konishi T; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Yamada Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Nagata A; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Nagata R; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Marumo A; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Noguchi Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Mukae J; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Toya T; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Igarashi A; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Najima Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Kobayashi T; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Harada H; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Harada Y; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences.
  • Sakamaki H; Clinical Research Support Center, Tokyo Metropolitan Cancer, and Infectious diseases Center Komagome Hospital.
  • Ohashi K; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
Rinsho Ketsueki ; 63(2): 104-107, 2022.
Article em Ja | MEDLINE | ID: mdl-35264498
ABSTRACT
Variants of the t (8;21) (q22;q22) involving chromosome 8, 21, and other chromosomes account for about 3% of all t (8;21) (q22;q22) in patients with acute myeloid leukemia (AML). However, the prognosis of AML with variant t (8;21) remains unknown due to the scarcity of reported cases. Herein we report a case of AML with t (6;21;8) (p23;q22;q22). Fluorescence in situ hybridization confirmed a RUNX1-RUNX1T1 fusion signal on the derivative chromosome 8. This is the first report on a variant of t (8;21) involving the breakpoint 6p23. After induction chemotherapy, our patient achieved complete remission and has been stable for four years.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cromossomos Humanos Par 8 / Leucemia Mieloide Aguda Tipo de estudo: Prognostic_studies Limite: Humans Idioma: Ja Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cromossomos Humanos Par 8 / Leucemia Mieloide Aguda Tipo de estudo: Prognostic_studies Limite: Humans Idioma: Ja Ano de publicação: 2022 Tipo de documento: Article